Nearly half of American workers may be quietly struggling with pain or illness that undermines their productivity, focus, and long-term well-being—and many don’t realize that stress may be the root cause. According to new survey data, 48% of Americans live with ongoing pain or physical symptoms that are either unexplained by injury or disease, or that fail to improve as expected with standard medical care. Experts now identify many of these cases as neuroplastic symptoms, a condition linked to changes in the brain’s neural pathways rather than structural damage to the body.
Dr. David Clarke, president of the Association for the Treatment of Neuroplastic Symptoms (ATNS), says the implications for employers are significant. “This suggests that it’s probably half the working population as well,” Clarke explains. “For employees suffering from these conditions, it’s probably affecting their productivity and potentially their ability to remain in the workplace.”
Neuroplastic symptoms can include chronic back pain, migraines, gastrointestinal distress, fatigue, and other persistent conditions that worsen under pressure. Research published largely within the past five years points to a growing understanding of how stress, unresolved emotions, and past trauma can rewire the brain in ways that generate real physical pain.
One of the most promising developments is Neuroplastic Recovery Therapy, a non-invasive, cost-effective approach rooted in education and talk therapy. In the Boulder Back Pain Study, participants who had suffered for an average of ten years experienced a 75% reduction in pain after just four weeks of treatment.
“Neuroplastic Recovery Therapy begins with education that pain or illness can be generated by the brain, thereby reducing patients’ fear of damage to their bodies,” Dr. Clarke says. “Shifting attention to how stress might be affecting the brain begins the process of healing.”
Unlike traditional treatments that focus solely on physical symptoms, this approach addresses the underlying neurological processes that perpetuate pain. Clarke notes that this shift represents a major advancement in treatment outcomes. “This is far more effective than approaches that have been used in the past,” he says.
For business leaders, the takeaway is clear. Chronic, stress-based pain doesn’t just affect individuals—it impacts attendance, engagement, healthcare costs, and retention. Educating employees about emerging treatment options and normalizing conversations around stress and mental health could lead to measurable improvements across organizations.
“And if employers help their employees become aware of these resources, it will undoubtedly help their employees’ health and well-being, their productivity, and their businesses tremendously,” Clarke adds.
As understanding of neuroplastic pain continues to evolve, experts say early awareness and education may be one of the most powerful tools employers have to support a healthier, more resilient workforce.